International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net
                                                                                                                                                                                                            
Copyright Policy

The copyright of all the manuscripts published by the IJPBS Journal is retained by the IJPBS journal. The copyright transfer and Agreement Forms submitted by the authors will vouch that all the publications are original work of the respective authors, unpublished/not considered for publication elsewhere.

The complete copyright transfer and agreement form (CTA) can be accessed from the link click here.

Some of the features of the CTA are:

1.    The author transfers the copyright of the submitting manuscript to the journal. He/She is free to use their published manuscript with appropriates citation to our journal without any commercial interest. If any commercial gains exist, the author or any other parties need to get written permission to use the same.

2.    The Conflict of Interest and/or Financial Disclosure should be mentioned in the manuscript. The latter is to declare any financial assistance received from any institution or organization for the conduct of the research.

3.    All articles published in IJPBS Journals are opted hybrid open-access articles, published and distributed under the terms of the Creative Commons Attribution 4.0 International Public License, which permits reproduction, distribution, derives and non-commercial use, provided the original work is properly cited and authors and publisher are properly identified. The details of the Creative Commons Attribution license can be obtained from the link click here.

4.    Authors and co-authors are bound to abide all rules and regulations which includes amended rules then and there without any conditions or restrictions. At any time either during the process or after publishing if IJPBS confirms the unethical practice suitable necessary action would be executed.

5.    All manuscript would be subjected to double-blind peer review by anonymous reviewers.

Creative commons Licencing

  • Authors who have consented to publish their work under Gold Open access and have paid the associated fees , are entitled to keep their article under public view under  CC BY-NC and CC BY-NC-ND  licence where author may share and distribute their article on non-commercial websites and repositories immediately upon publication.

  • Authors who have consented to publish their work under Green Open access and have paid the associated fees , are entitled to keep their article under public view under  CC BY-NC and CC BY-NC-ND  licence where author may share and distribute their article on non-commercial websites and repositories only after the embargo period.

  • Authors who have consented to publish their work under subscription model are entitled to keep their article under public view under  CC BY-NC and CC BY-NC-ND  licence where author may share and distribute their article abstract and hyperlinking to the full text to our journal respective abstract page or its DOI .Embargo period for this starts once the journal releases the article for free open / public access.

 


 

 

Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech SolutionsHome I Contact I Terms & Conditions